Opinion
Video
Author(s):
Key opinion leaders explore strategies for managing common side effects associated with metastatic castration-resistant prostate cancer (mCRPC) treatments, including androgen receptor-targeted therapies.
How do you manage common side effects associated with mCRPC treatments, including androgen receptor-targeted therapies?
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.